These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12588237)

  • 1. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.
    Baumann LS; Halem ML
    Arch Dermatol; 2003 Feb; 139(2):226-7. PubMed ID: 12588237
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
    Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
    Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
    [No Abstract]   [Full Text] [Related]  

  • 3. Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.
    Lehman JS
    Arch Dermatol; 2011 Jun; 147(6):752. PubMed ID: 21690551
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Mallin K; Charles C; Martin LK; Black L; Bryde J
    Dermatol Surg; 2005 Mar; 31(3):263-70. PubMed ID: 15841624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
    Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?
    Kouris A; Vavouli C; Markantoni V; Kontochristopoulos G
    J Drugs Dermatol; 2014 Nov; 13(11):1315-6. PubMed ID: 25607695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.
    Glaser DA
    Neurotox Res; 2006 Apr; 9(2-3):173-7. PubMed ID: 16785115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.
    Chiarello D; Piombo M; Corbetto M; Di Pino G; Assenza G; Capone F; Di Lazzaro V
    Muscle Nerve; 2014 Sep; 50(3):456-7. PubMed ID: 24890202
    [No Abstract]   [Full Text] [Related]  

  • 11. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2014 Jun; 70(6):1083-7. PubMed ID: 24630001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
    Glogau RG
    Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 15. Palmar hyperhidrosis in a 13-year-old boy: treatment with botulinum toxin A.
    Vázquez-López ME; Pego-Reigosa R
    Clin Pediatr (Phila); 2005; 44(6):549-51. PubMed ID: 16015405
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic side effects of botulinum toxin type B therapy.
    Dressler D; Benecke R
    Adv Neurol; 2004; 94():315-20. PubMed ID: 14509689
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
    Naumann M; Lowe NJ
    BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does wrist nerve block influence the result of botulinum toxin A treatment in palmar hyperhidrosis?
    Hund M; Rickert S; Kinkelin I; Naumann M; Hamm H
    J Am Acad Dermatol; 2004 Jan; 50(1):61-2. PubMed ID: 14699366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hyperhidrosis with botulinum toxin.
    Doft MA; Hardy KL; Ascherman JA
    Aesthet Surg J; 2012 Feb; 32(2):238-44. PubMed ID: 22328694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.